deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT02681302

Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence (CPIT001)

Phase Ib-IIA Study of Combined Check Point Inhibition After Autologous Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence

Sponsor: Hackensack Meridian Health

Conditions Lymphoma Multiple Myeloma
Interventions Ipilimumab Nivolumab
Updated 20 times since 2017 Last updated: Jul 7, 2025 Started: Jun 7, 2016 Primary completion: May 10, 2024 Completion: May 10, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of Accrual

Other terminated trials from Hackensack Meridian Health

See all terminations from Hackensack Meridian Health

Other Lymphoma trials with similar outcome

Browse all Lymphoma trials

A PHASE1/PHASE2 clinical study on Lymphoma and Multiple Myeloma, this trial is terminated or withdrawn. The trial is conducted by Hackensack Meridian Health and has accumulated 20 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Jul 2019 · 8 months · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~May 2020 · 8 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Jan 2022 · 7 months · monthly snapshot~Jan 2022 – ~Jan 2023 · 12 months · monthly snapshot~Jan 2023 – ~Apr 2023 · 3 months · monthly snapshot~Apr 2023 – ~Mar 2024 · 11 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Aug 2025 — Sep 2025 [monthly]

    Terminated PHASE1/PHASE2

  3. Sep 2024 — Aug 2025 [monthly]

    Terminated PHASE1/PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Status: Active Not Recruiting → Terminated · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  5. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 15 earlier versions

  1. Apr 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Jan 2023 — Apr 2023 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Jan 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Jun 2021 — Jan 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE1_PHASE2

  6. May 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  7. Sep 2019 — May 2020 [monthly]

    Recruiting PHASE1_PHASE2

  8. Jul 2019 — Sep 2019 [monthly]

    Recruiting PHASE1_PHASE2

  9. Nov 2018 — Jul 2019 [monthly]

    Recruiting PHASE1_PHASE2

  10. Sep 2018 — Nov 2018 [monthly]

    Recruiting PHASE1_PHASE2

  11. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE1_PHASE2

  12. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1_PHASE2

  13. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  14. Feb 2017 — Aug 2017 [monthly]

    Recruiting PHASE1_PHASE2

  15. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hackensack Meridian Health
Data source: Hackensack Meridian Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations